TUMOR IMMUNOLOGY by A. G. Dalgleish (Editor), M.J. Browning (Editor), Karol Sikora (Foreword) ( 9780521159470 )

Item Details

Title:

TUMOR IMMUNOLOGY
IMMUNOTHERAPY AND CANCER VACCINES

By:

A. G. Dalgleish (Editor), M.J. Browning (Editor), Karol Sikora (Foreword)

Format:

Paperback

List price:

£43.99

Our price:

£38.49

Discount:

12.5% off

You save:

£5.50

ISBN 10:

0521159474

ISBN 13:

9780521159470

Availability:

Usually dispatched within 1-3 weeks.

Delivery rates

Stock:

Currently 0 available

Publisher:

CAMBRIDGE UNIVERSITY PRESS

Pub. date:

2 September, 2010

Series:

Cancer: Clinical Science in Practice

Pages:

374

Description:

This 1996 volume reviewed advances in the field of human tumour immunology for an audience of clinicians and researchers.

Synopsis:

This 1996 volume reviewed advances in the field of human tumour immunology, particularly in relation to the potential for immune intervention in preventing or treating tumours. The editors and contributors, all prominent workers in the field, survey advances in the understanding of the relationship between the cancer cell and the immune response at the time of publication. Chapters review in depth the function of immune surveillance and mechanisms of tumour immunity, the role of T lymphocytes and oncogenes in the immune response to cancer, and the potential for immunotherapy of cancer. Areas of tumour immunology that were new at the time of this book's publication are presented, including progress in the development of tumour vaccines with particular reference to melanoma. The volumes in this series are intended for a wide audience of clinicians and researchers with an interest in the applications of biomedical science to the understanding and management of cancer.

Publication:

Imprint:

Cambridge University Press

Returns:

Returnable

Some other items by this author:

AN INTRODUCTION TO PSYCHO-ONCOLOGY (HB)

AN INTRODUCTION TO PSYCHO-ONCOLOGY (PB)

ANNI'S CANCER COMPANION (PB)

CANCER: THE KEY TO GETTING THE BEST CARE

CANCER: THE KEY TO GETTING THE BEST CARE (HB)

DRUG RESISTANCE IN THE TREATMENT OF CANCER